Filipa Ramos-Oliveira

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Emapalumab's role in a severe and treatment-resistant paediatric macrophage activation syndrome.

Emapalumab's role in a severe and treatment-resistant paediatric macrophage activation syndrome.

Journal: ARP rheumatology

Published: April 12, 2026

Long-term comorbidity patterns in juvenile idiopathic arthritis.

Long-term comorbidity patterns in juvenile idiopathic arthritis.

Journal: Clinical and experimental rheumatology

Published: November 23, 2025

Bridging the gap between 2024 EULAR/PreS Recommendations for Still's Disease and practice: the need for awareness of biomarkers and timely use of IL-1/ IL-6 inhibition.

Bridging the gap between 2024 EULAR/PreS Recommendations for Still's Disease and practice: the need for awareness of biomarkers and timely use of IL-1/ IL-6 inhibition.

Journal: ARP rheumatology

Published: July 09, 2025

Juvenile dermatomyositis: a severe and atypical presentation.

Juvenile dermatomyositis: a severe and atypical presentation.

Journal: ARP rheumatology

Published: July 09, 2025

Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action.

Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action.

Journal: Rheumatology advances in practice

Published: May 20, 2025

Challenges in the transition of care for rare connective tissue diseases: results from the 2023 ERN ReCONNET Transition of Care Task Force survey.

Challenges in the transition of care for rare connective tissue diseases: results from the 2023 ERN ReCONNET Transition of Care Task Force survey.

Journal: Rheumatology advances in practice

Published: July 01, 2024

A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis.

A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis.

Journal: Best practice & research. Clinical rheumatology

Published: March 29, 2024

EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.

EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.

Journal: Annals of the rheumatic diseases

Published: March 21, 2024

The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C.

The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C.

Journal: Journal of autoimmunity

Published: February 14, 2024

Eosinophilic Granulomatosis with Polyangiitis - description of a pediatric patient with severe disease.

Eosinophilic Granulomatosis with Polyangiitis - description of a pediatric patient with severe disease.

Journal: ARP rheumatology

Published: July 08, 2023

Characterization of three adults and an adolescent with Osteogenesis Imperfecta type VI and a novel founder SERPINF1 variant.

Characterization of three adults and an adolescent with Osteogenesis Imperfecta type VI and a novel founder SERPINF1 variant.

Journal: European journal of medical genetics

Published: June 11, 2023

Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes.

Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes.

Journal: Arthritis research & therapy

Published: March 26, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026